- Before starting abstract submission, read the Instructions and Guidelines!
- Prepare your abstract in a Microsoft Word document to be copied and pasted during abstract submission.
- Abstract body (including Title, Authors, Affiliation, and Financial Support Information) should NOT exceed 3600 characters (including spaces). Indicate the institution of each author.
- Capitalize only the Initial Letters in the Abstract Title. For example: Gastroprotective Effect of Lonchocarpus sericeus on Ethanol-Induced Gastric Lesion in Mice: Role of Prostaglandins and Nitric Oxide.
- Use standard abbreviations for units of measure. Other abbreviations should be spelled out in full at first mention, followed by the abbreviation in parentheses. Exceptions: AMPc, EGTA, DNA, RNA etc.
- The abstracts must be divided into: Introduction, Methods, Results, and Conclusion. Financial Support and the approval by Human or Animal Research Ethical Committee should be included, when applied.
- References: Quote the first author, abbreviated journal, volume, first page and year. For example: Kahn, RS. Nat. Rev. Dis. Prim., v. 1, p. 1, 2015.
- DO NOT include tables or figures. DO NOT underline, italicize, except for scientific names, or embolden any word.
- Allocate the Acknowledgments at the end of the abstract.
- Important: When applicable, approval by Human or Animal Research Ethical Committee and the financial support MUST be indicated. The absence of both information will not allow the abstract submission to be completed. In case of any doubt, contact SBFTE secretariat (email@example.com).
- Literature Reviews or projects will not be accepted.
- For authors DO NOT USE as a surname: Filho, Sobrinho, Neto, or Junior. Use for example: Carvalho-Júnior, Silva Neto JA.
Online abstract submission
- Abstracts should be submitted electronically from March 24th to May 26th, 2023 (11:59 PM BRT).
- Only Abstracts in English will be accepted.
- Only ONE abstract per registration (author or coauthor) will be accepted.
- All submitted abstracts will be evaluated by an Abstract Evaluation Committee.
- By default, all approved abstracts will be considered for a poster presentation.
- If you are an Undergraduate or Graduate Student (Master or Doctoral Degree): Indicate during online abstract submission your preference to be considered for an Oral Communication. The Oral Communication must be in English.
- The Scientific Program Committee reserves the right to select few abstracts for Oral Communications.
- Abstracts presented as Oral Communications will also have to be presented as posters. Only first authors are allowed to deliver the Oral Communication.
- Graduate Student (Master or Doctoral Degree) or a young researcher that has received the doctoral degree in the last 5 years (2018-2022) may indicate, during online abstract submission, your preference for considering your abstract for the Jose Ribeiro do Valle Award (JRV). See rules for JRV Award below.
- Undergraduate Students and Graduate Students (members and nonmembers): The advisor/supervisor will receive an E-mail to confirm the student status when submitting abstract and/or registering online.
- Click on Online Registration to begin your abstract submission
- Attention: After abstract submission, no alteration of the title and authors’ names will be allowed.
01. Cellular and Molecular Pharmacology
04. Inflammation and Immunopharmacology
05. Pain and Nociception Pharmacology
06. Cardiovascular and Renal Pharmacology
07. Endocrine, Reproductive and Urinary Pharmacology
08. Respiratory and Gastrointestinal Pharmacology
09. Natural Products and Toxinology
10. Cancer Pharmacology
11. Clinical Pharmacology, Pharmacokinetics, Pharmacogenomics and Toxicology
12. Drug Discovery and Development
13. Pharmacology Education and Technology
14. Pharmacology: Other